Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 22Carcinoma, Non-Small-Cell Lung 12Lung Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Lymphoma, Mantle-Cell 8Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8Head and Neck Neoplasms 8Congenital Abnormalities 7Breast Neoplasms, Male 7Unspecified Adult Solid Tumor, Protocol Specific 6Squamous Cell Carcinoma of Head and Neck 6Myeloproliferative Disorders 6Multiple Myeloma 6Melanoma 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Large B-Cell, Diffuse 6Leukemia 6Carcinoma, Ovarian Epithelial 6Prostatic Neoplasms 5Neoplasms, Plasma Cell 5Neoplasms 5Myelodysplastic Syndromes 5Lymphoma 5Leukemia, Myeloid, Acute 5Hodgkin Disease 5Colonic Neoplasms 5Burkitt Lymphoma 5

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Immunoenzyme Techniques × Clear all
NCT00410956 2024-12-10

Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
22 enrolled 12 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00513461 2018-08-10

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

University of California, Irvine

Phase 2 Completed
110 enrolled 21 charts
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
54 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡